Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era

Aim: To describe the chickenpox complications in children in Italy. Methods: Hospital discharge data from 1 January 2002 to 15 June 2006 were queried for patients less than 18 years of age in three Italian paediatric university hospitals. Results: During the study period, 349 children (189 males, 16...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Paediatrica 2007-10, Vol.96 (10), p.1490-1493
Hauptverfasser: Marchetto, S, De Benedictis, F M, De Martino, M, Versace, A, Chiappini, E, Bertaine, C, Osimani, P, Cordiali, R, Gabiano, C, Galli, L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: To describe the chickenpox complications in children in Italy. Methods: Hospital discharge data from 1 January 2002 to 15 June 2006 were queried for patients less than 18 years of age in three Italian paediatric university hospitals. Results: During the study period, 349 children (189 males, 160 females) were admitted. Thirteen out of 349 (3.7%) of them had serious underlying diseases. Two hundred and sixty‐one (74.8%) children (median age: 41 months, range: 6 days –to 200 months) had complicated chickenpox. Among complications, neurological disorders were the most common (100/261 = 38.3%), followed by skin and soft tissue infections (63/261 = 24.1%), lower respiratory tract infections (57/261 = 21.8%) and haematological disorders (24/261 = 9.2%). Children with neurological complications were significantly older and had a longer hospital stay than those with other complications. Three children with encephalitis and cerebellitis had developed long‐term sequelae by the 6‐month follow‐up. The mortality rate was 0.4% (1/261 children with complicated chickenpox). Conclusion: Chickenpox is a disease that can provoke serious complications and long hospital stays, even in healthy children. Our findings may be useful as background to evaluate the impact of a tetravalent measles‐mumps‐rubella‐varicella vaccine (MMRV) which is going to be introduced in Italy.
ISSN:0803-5253
1651-2227
DOI:10.1111/j.1651-2227.2007.00465.x